Literature DB >> 35822084

Distinctive Energy Profile of Water-Soluble, Thiolate-Protected Gold Nanoparticles as Potential Molecular Marker for Vulnerable Plaque Detection with XFCT Imaging.

Raiyan T Zaman1, Don Vernekhol2, Lei Xing2.   

Abstract

Purpose: X-ray CT plays a pivotal role in diagnostic imaging, radiotherapy, and its indispensable contribution to preclinical small animal imaging research. This study characterizes a distinctive energy spectrum of a novel 3-mercaptobenzoic-acid (3MBA)-protected-144-atoms gold-nanoparticles (3MBA-Au-144-NPs) after X-ray excitation and detects vulnerable atherosclerotic plaques non-invasively using this novel contrast agent in mice carotid arteries for the first time to the best of our knowledge.
Methods: We designed a four-chamber heart apex model using a 3D-printer and filled with four different concentrations of 3MBA-Au-144-NPs. The X-ray system was equipped with a pencil beam collimator, which was calibrated using a 1×1 in2 large radiochromic film. The tube was operated at 320 kVp with 12.5 mA current and multiple filtration options were available for the X-ray excitation source. The resulting pencil beam had a 3.2 mm diameter. The four-chamber apex was translated and rotated relative to the stationary pencil beam. Each sample chamber was irradiated for 2-minutes and emitted fluorescent X-rays from the excited 3MBA-Au-144-NPs were collected with CdTe and Silicon Drift (SD) detectors for 15 seconds. The spectra were used for L-shell XRF peak isolation and sonogram generation of this novel 3MBA-Au-144-NPs. The distribution and concentration of 3MBA-Au-144-NPs were reconstructed with an alternative maximum likelihood expectation maximization algorithm. For in vivo detection of unstable plaques, we developed atherosclerotic mice model after feeding them 1% high cholesterol diet (HCD) for four weeks before diabetic was induced by intraperitoneal injection of streptozotocin (STZ) to accelerate the plaque progression. Two weeks after the diabetic induction, surgically left carotid artery was ligated. Two weeks after the surgical ligation, a 250 μL of 3MBA-Au-144-NPs was IV injected after 6 hours of fasting. One hour after injection, the mice were imaged non-invasively with a cone-beam micro-CT system.
Results: Two distinctive L-shell energy peaks were observed at 10 KeV and 11.13 KeV for 3MBA-Au-144-NPs in the energy spectrum of the SD detector. K-shell fluorescence events vanished in the Compton scatter and characteristic background of the tungsten source due to the lead shielding for the SD and CdTe detectors. There is a space missing at 12.5 KeV. The signal intensity varied with different 3MBA-Au-144-NPs concentration of 5%, 10%, 20%, and 100%. The X-ray fluorescence (XRF) intensity showed a highly linear response (R2=0.999) with respect to different concentrations of 3MBA-Au-144-NPs. High XRF signal was detected in the left carotid artery at 2 mm below the ligation and in aortic arch. Non-ligated right carotid artery (negative control) showed no such signal.
Conclusion: These distinct energy spectra in the L-shell fluorescent energies render 3MBA-Au-144-NPs as a viable contrast agent for future in vivo XFCT imaging.

Entities:  

Year:  2020        PMID: 35822084      PMCID: PMC9272981     

Source DB:  PubMed          Journal:  J Radiol Radiat Ther        ISSN: 2333-7095


  13 in total

1.  Investigation of X-ray fluorescence computed tomography (XFCT) and K-edge imaging.

Authors:  Magdalena Bazalova; Yu Kuang; Guillem Pratx; Lei Xing
Journal:  IEEE Trans Med Imaging       Date:  2012-06-05       Impact factor: 10.048

2.  The feasibility of polychromatic cone-beam x-ray fluorescence computed tomography (XFCT) imaging of gold nanoparticle-loaded objects: a Monte Carlo study.

Authors:  Bernard L Jones; Sang Hyun Cho
Journal:  Phys Med Biol       Date:  2011-05-31       Impact factor: 3.609

3.  A quantitative x-ray detection system for gold nanoparticle tumour biomarkers.

Authors:  K Ricketts; A Castoldi; C Guazzoni; C Ozkan; C Christodoulou; A P Gibson; G J Royle
Journal:  Phys Med Biol       Date:  2012-08-08       Impact factor: 3.609

4.  Plane polarized x-ray fluorescence system for the in vivo measurement of platinum in head and neck tumours.

Authors:  P A Ali; A F Al-Hussany; C A Bennett; D A Hancock; A M El-Sharkawi
Journal:  Phys Med Biol       Date:  1998-08       Impact factor: 3.609

5.  First demonstration of multiplexed X-ray fluorescence computed tomography (XFCT) imaging.

Authors:  Yu Kuang; Guillem Pratx; Magdalena Bazalova; Bowen Meng; Jianguo Qian; Lei Xing
Journal:  IEEE Trans Med Imaging       Date:  2012-10-11       Impact factor: 10.048

6.  X-ray fluorescence computed tomography (XFCT) imaging of gold nanoparticle-loaded objects using 110 kVp x-rays.

Authors:  Seong-Kyun Cheong; Bernard L Jones; Arsalan K Siddiqi; Fang Liu; Nivedh Manohar; Sang Hyun Cho
Journal:  Phys Med Biol       Date:  2010-01-13       Impact factor: 3.609

7.  Development of XFCT imaging strategy for monitoring the spatial distribution of platinum-based chemodrugs: instrumentation and phantom validation.

Authors:  Yu Kuang; Guillem Pratx; Magdalena Bazalova; Jianguo Qian; Bowen Meng; Lei Xing
Journal:  Med Phys       Date:  2013-03       Impact factor: 4.071

8.  Experimental demonstration of benchtop x-ray fluorescence computed tomography (XFCT) of gold nanoparticle-loaded objects using lead- and tin-filtered polychromatic cone-beams.

Authors:  Bernard L Jones; Nivedh Manohar; Francisco Reynoso; Andrew Karellas; Sang Hyun Cho
Journal:  Phys Med Biol       Date:  2012-11-08       Impact factor: 3.609

9.  Synthesis of Water-Soluble, Thiolate-Protected Gold Nanoparticles Uniform in Size.

Authors:  Maia Azubel; Roger D Kornberg
Journal:  Nano Lett       Date:  2016-04-19       Impact factor: 11.189

10.  Near infrared imaging and photothermal ablation of vascular inflammation using single-walled carbon nanotubes.

Authors:  Hisanori Kosuge; Sarah P Sherlock; Toshiro Kitagawa; Rajesh Dash; Joshua T Robinson; Hongjie Dai; Michael V McConnell
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.